SlideShare une entreprise Scribd logo
1  sur  18
Télécharger pour lire hors ligne
RICKETTSIA
Dr. Punit Jhandai
Veterinary Public Health
Department
LUVAS(125004), Hisar RICKETTSIA INSIDE
THE ENDOTHELIAL
CELLS
Introduction
• Obligate intracellular parasite.
• Gram negative
• Parasite of arthropods – fleas, lice, ticks and mites.
• No Human to human transmission.
• Despite the similar name, Rickettsia bacteria do not cause
rickets, which is a result of vitamin D deficiency.
• In the past, positioned somewhere between viruses and
true bacteria.
Introduction
• Pleomorphic coccobacilli
• Non Motile, Non Capsulated.
• Stain bluish purple with Giemsa and deep red with
Machiavello.
• Optimum temp for growth 32-35°C
• Generally occur in cytoplasm of infective cell but in
some case also occur in nucleus of cell.
• Readily inactivated by physical and chemical agents,
rapidly destroyed at 56°C
• Glutamate is key nutrient for rickettsia.
Pathogenesis
• Rickettsia are transmitted to humans by the
bite of infected arthropod vector.
• Multiply at the site of entry and enter the
blood stream.
• Localise in the vascular endothelial cells and
multiply to cause thrombosis with partial or
complete occlusion of vascular lumen, lead to
rupture & necrosis.
• Overall pathological features of the rickettsial
diseases are similar as the cause acute febrile
illness, characterised by septicemia with
maculopaspular rash and fever.
Rickettsial species and its disease
• R. prowazekii – Epidemic typhus, Brill-
Zinsser disease – Human body louse
• R. typhi – Endemic typhus – Rat flea
• R. rickettsii – Rocky-Mountain spotted
fever-Ticks
• R. akari – Rickettsial pox - Mites
EPIDEMIC TYPHUS (CLASSICAL TYPHUS)
Cause: Rickettsia prowazekii
Vector: Human body louse ( Pediculus humanus
corporis) Human head louse ( Pediculus humanus capitis)
Incubation period – 5-15 days
Mortality rate is 30-40% in untreated cases.
Symptoms- Severe headache, Chills , Generalised
myalgia, High fever ( 39-410C), Vomiting, Macular rash
after 4-7 days – first on trunk and spreads to limb.
Brill –Zinsser/ Recrudescent typhus
This occur after the person recovered from
epidemic typhus and reactivation of the rickettsia
prowazekii which remained latent for years.
ENDEMIC TYPHUS (MURINE TYPHUS)
Cause- R. typhi
Vector: Rat flea (Xenopsylla cheopis)
Reservoir: Rat
Infection occurs after rat flea bite
Rickettsia multiply in gut of flea and is shed in
feaces.
Spotted fever group
Rickettsiae of this group multiply in nucleus as well as
in the cytoplasm of the host.
Tick typhus- Transmit Transovarially in ticks, and
transmission to human being is primarily by bite.
Indian tick typhus- caused by R. conori
Vector- Rhipicephalus sanguineus
Rocky mountain spotted fever- Most serious form
Cause – R. rickettsii
Infection occurs after tick(Dermacentor andersoni) bite
Incubation period – 1 week
More similar to typhus fever but the rash appears earlier
and is more prominent.
Rickettsial pox- Mildest rickettsial
Diseases of human, self limiting,
Non fatal, resemble to chicken pox so
Known as vesicular rickettsiosis
Caused by R. akari and transmit by mite
(Mus musculus)
LABORATORY DIAGNOSIS
Direct Microscopy
Culture- Yolk sac of emryonated hens egg, male guinea
pig, cell tissue culture
Serological test- Weil Felix rxn, CFT, IFA, ELISA
LABORATORY DIAGNOSIS
• Isolation from experimental animals
Blood is inoculated in guinea pigs/mice.
Observed on 3rd – 4th week.
Animal responds to different rickettsial species can vary
Symptoms:
Rise in temperature – all species.
Scrotal inflammation, swelling, necrosis – R. typhi, R.conori,
R. akari ( except R. prowazekii)
This is known as Neil Mooser Rxn
Specimens: Blood – collected in febrile illness
Note: Rickettsia is highly infectious so specimens should be
handled very carefully.
Serology- Reliable test to confirm rickettsial diseases
Antibody detection by Weil-felix test
Antigen detection by IFA
Weil-felix test- Heterophile agglutination test using
non motile proteus strains (OX 19, OX 2, OX K)
to find rickettsial antibodies in patient’s serum.
Procedure:
1. Serum is diluted in three separate series of tubes
followed by the addition of equal amount of
OX19,OX2,OXK in 3 separate series of tubes.
2. Incubation at 370C for overnight.
3. Observe for agglutination
INTERPRETATION OF WEIL-FELIX TEST
• Strong Agglutination with OX 19 – means epidemic &
endemic typhus.
• Strong agglutination with OX 19 & OX 2 - means Spotted
fever
• Strong agglutination with OX K – Scrub typhus
(Scrub typhus by Orientia tsutsugamushi
(one of the rickettsial disease)
IMMUNOFLUORESCENT ANTIBODY TECHNIQUE – UTILISES
FLUORESCENT ANTIBODY TO DETECT RICKETTSIAL
ANTIGEN IN INFECTED TISSUES
Treatment
Treatment should be started early in the first week
of illness.
Doxycycline (first choice)
Tetracycline (alternate)
PROPHYLAXIS
Vector control

Contenu connexe

Similaire à rickettsiabypunit-copy-170914153220.pdf (20)

Rickketsiaece
RickketsiaeceRickketsiaece
Rickketsiaece
 
Rickettsia and chlamydia
Rickettsia and chlamydiaRickettsia and chlamydia
Rickettsia and chlamydia
 
Rickettsia by Dr. Rakesh Prasad Sah.pptx
Rickettsia by Dr. Rakesh Prasad Sah.pptxRickettsia by Dr. Rakesh Prasad Sah.pptx
Rickettsia by Dr. Rakesh Prasad Sah.pptx
 
Rickettsia & chlamydia presentation.
Rickettsia & chlamydia presentation.Rickettsia & chlamydia presentation.
Rickettsia & chlamydia presentation.
 
Ricketssia
RicketssiaRicketssia
Ricketssia
 
Rickettsia
RickettsiaRickettsia
Rickettsia
 
Bhuwan (rickettsial disease)
Bhuwan (rickettsial disease)Bhuwan (rickettsial disease)
Bhuwan (rickettsial disease)
 
Rickettsia
RickettsiaRickettsia
Rickettsia
 
Rickettsiae
RickettsiaeRickettsiae
Rickettsiae
 
Rhabdovirus lecture
Rhabdovirus lectureRhabdovirus lecture
Rhabdovirus lecture
 
RICKETTSIACEAE
RICKETTSIACEAERICKETTSIACEAE
RICKETTSIACEAE
 
Lecture enteroviruses
Lecture enterovirusesLecture enteroviruses
Lecture enteroviruses
 
Zoonotic infections.ppt
Zoonotic infections.pptZoonotic infections.ppt
Zoonotic infections.ppt
 
Picorna viruses
Picorna virusesPicorna viruses
Picorna viruses
 
Rickettsia
RickettsiaRickettsia
Rickettsia
 
Rickettsial ds
Rickettsial dsRickettsial ds
Rickettsial ds
 
Reckettsia dr.ihsan alsaimary
Reckettsia dr.ihsan alsaimaryReckettsia dr.ihsan alsaimary
Reckettsia dr.ihsan alsaimary
 
Rickettsial diseases
Rickettsial diseasesRickettsial diseases
Rickettsial diseases
 
Rickettsial zoonoses
Rickettsial zoonosesRickettsial zoonoses
Rickettsial zoonoses
 
Typhus: the Rickettsial Disease
Typhus: the Rickettsial DiseaseTyphus: the Rickettsial Disease
Typhus: the Rickettsial Disease
 

Plus de SyedMuhammadZakria

drugresistanceactivity-201223143521.pdf
drugresistanceactivity-201223143521.pdfdrugresistanceactivity-201223143521.pdf
drugresistanceactivity-201223143521.pdfSyedMuhammadZakria
 
mycobacteria-150411210246-conversion-gate01.pdf
mycobacteria-150411210246-conversion-gate01.pdfmycobacteria-150411210246-conversion-gate01.pdf
mycobacteria-150411210246-conversion-gate01.pdfSyedMuhammadZakria
 
emanemufassalbybasheer-221122003724-5b47b246 (2).pdf
emanemufassalbybasheer-221122003724-5b47b246 (2).pdfemanemufassalbybasheer-221122003724-5b47b246 (2).pdf
emanemufassalbybasheer-221122003724-5b47b246 (2).pdfSyedMuhammadZakria
 
hypersensitivity-200313073251.pdf
hypersensitivity-200313073251.pdfhypersensitivity-200313073251.pdf
hypersensitivity-200313073251.pdfSyedMuhammadZakria
 
Hemolytic disease of newborn. GHS.pptx
Hemolytic disease of newborn. GHS.pptxHemolytic disease of newborn. GHS.pptx
Hemolytic disease of newborn. GHS.pptxSyedMuhammadZakria
 
introductiontoclinicalchemistry-150421021353-conversion-gate01.pdf
introductiontoclinicalchemistry-150421021353-conversion-gate01.pdfintroductiontoclinicalchemistry-150421021353-conversion-gate01.pdf
introductiontoclinicalchemistry-150421021353-conversion-gate01.pdfSyedMuhammadZakria
 
Lecture 4-Medical Mycology-.ppt
Lecture 4-Medical Mycology-.pptLecture 4-Medical Mycology-.ppt
Lecture 4-Medical Mycology-.pptSyedMuhammadZakria
 
lecture29-chlamydia-131112214406-phpapp01.pdf
lecture29-chlamydia-131112214406-phpapp01.pdflecture29-chlamydia-131112214406-phpapp01.pdf
lecture29-chlamydia-131112214406-phpapp01.pdfSyedMuhammadZakria
 
immunodeficiency1-181026134939.pdf
immunodeficiency1-181026134939.pdfimmunodeficiency1-181026134939.pdf
immunodeficiency1-181026134939.pdfSyedMuhammadZakria
 
Cell Membrane & it-s Functions.pdf
Cell Membrane & it-s Functions.pdfCell Membrane & it-s Functions.pdf
Cell Membrane & it-s Functions.pdfSyedMuhammadZakria
 

Plus de SyedMuhammadZakria (16)

drugresistanceactivity-201223143521.pdf
drugresistanceactivity-201223143521.pdfdrugresistanceactivity-201223143521.pdf
drugresistanceactivity-201223143521.pdf
 
mycobacteria-150411210246-conversion-gate01.pdf
mycobacteria-150411210246-conversion-gate01.pdfmycobacteria-150411210246-conversion-gate01.pdf
mycobacteria-150411210246-conversion-gate01.pdf
 
emanemufassalbybasheer-221122003724-5b47b246 (2).pdf
emanemufassalbybasheer-221122003724-5b47b246 (2).pdfemanemufassalbybasheer-221122003724-5b47b246 (2).pdf
emanemufassalbybasheer-221122003724-5b47b246 (2).pdf
 
hypersensitivity-200313073251.pdf
hypersensitivity-200313073251.pdfhypersensitivity-200313073251.pdf
hypersensitivity-200313073251.pdf
 
Hemolytic disease of newborn. GHS.pptx
Hemolytic disease of newborn. GHS.pptxHemolytic disease of newborn. GHS.pptx
Hemolytic disease of newborn. GHS.pptx
 
ایفائے عہد2 (1).pptx
ایفائے عہد2 (1).pptxایفائے عہد2 (1).pptx
ایفائے عہد2 (1).pptx
 
elisa-220428090127.pdf
elisa-220428090127.pdfelisa-220428090127.pdf
elisa-220428090127.pdf
 
introductiontoclinicalchemistry-150421021353-conversion-gate01.pdf
introductiontoclinicalchemistry-150421021353-conversion-gate01.pdfintroductiontoclinicalchemistry-150421021353-conversion-gate01.pdf
introductiontoclinicalchemistry-150421021353-conversion-gate01.pdf
 
blunt trauma wounds-2.pptx
blunt trauma wounds-2.pptxblunt trauma wounds-2.pptx
blunt trauma wounds-2.pptx
 
coagulation-181225200840.pdf
coagulation-181225200840.pdfcoagulation-181225200840.pdf
coagulation-181225200840.pdf
 
Lecture 4-Medical Mycology-.ppt
Lecture 4-Medical Mycology-.pptLecture 4-Medical Mycology-.ppt
Lecture 4-Medical Mycology-.ppt
 
lecture29-chlamydia-131112214406-phpapp01.pdf
lecture29-chlamydia-131112214406-phpapp01.pdflecture29-chlamydia-131112214406-phpapp01.pdf
lecture29-chlamydia-131112214406-phpapp01.pdf
 
ranjithakm-180315143057.pdf
ranjithakm-180315143057.pdfranjithakm-180315143057.pdf
ranjithakm-180315143057.pdf
 
immunodeficiency1-181026134939.pdf
immunodeficiency1-181026134939.pdfimmunodeficiency1-181026134939.pdf
immunodeficiency1-181026134939.pdf
 
Cell Membrane & it-s Functions.pdf
Cell Membrane & it-s Functions.pdfCell Membrane & it-s Functions.pdf
Cell Membrane & it-s Functions.pdf
 
Blood Groups.pptx
Blood Groups.pptxBlood Groups.pptx
Blood Groups.pptx
 

Dernier

Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterMateoGardella
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docxPoojaSen20
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Disha Kariya
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docxPoojaSen20
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfSanaAli374401
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 

Dernier (20)

Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 

rickettsiabypunit-copy-170914153220.pdf

  • 1. RICKETTSIA Dr. Punit Jhandai Veterinary Public Health Department LUVAS(125004), Hisar RICKETTSIA INSIDE THE ENDOTHELIAL CELLS
  • 2. Introduction • Obligate intracellular parasite. • Gram negative • Parasite of arthropods – fleas, lice, ticks and mites. • No Human to human transmission. • Despite the similar name, Rickettsia bacteria do not cause rickets, which is a result of vitamin D deficiency. • In the past, positioned somewhere between viruses and true bacteria.
  • 3. Introduction • Pleomorphic coccobacilli • Non Motile, Non Capsulated. • Stain bluish purple with Giemsa and deep red with Machiavello. • Optimum temp for growth 32-35°C • Generally occur in cytoplasm of infective cell but in some case also occur in nucleus of cell. • Readily inactivated by physical and chemical agents, rapidly destroyed at 56°C • Glutamate is key nutrient for rickettsia.
  • 4.
  • 5. Pathogenesis • Rickettsia are transmitted to humans by the bite of infected arthropod vector. • Multiply at the site of entry and enter the blood stream. • Localise in the vascular endothelial cells and multiply to cause thrombosis with partial or complete occlusion of vascular lumen, lead to rupture & necrosis. • Overall pathological features of the rickettsial diseases are similar as the cause acute febrile illness, characterised by septicemia with maculopaspular rash and fever.
  • 6.
  • 7. Rickettsial species and its disease • R. prowazekii – Epidemic typhus, Brill- Zinsser disease – Human body louse • R. typhi – Endemic typhus – Rat flea • R. rickettsii – Rocky-Mountain spotted fever-Ticks • R. akari – Rickettsial pox - Mites
  • 8. EPIDEMIC TYPHUS (CLASSICAL TYPHUS) Cause: Rickettsia prowazekii Vector: Human body louse ( Pediculus humanus corporis) Human head louse ( Pediculus humanus capitis) Incubation period – 5-15 days Mortality rate is 30-40% in untreated cases. Symptoms- Severe headache, Chills , Generalised myalgia, High fever ( 39-410C), Vomiting, Macular rash after 4-7 days – first on trunk and spreads to limb.
  • 9. Brill –Zinsser/ Recrudescent typhus This occur after the person recovered from epidemic typhus and reactivation of the rickettsia prowazekii which remained latent for years. ENDEMIC TYPHUS (MURINE TYPHUS) Cause- R. typhi Vector: Rat flea (Xenopsylla cheopis) Reservoir: Rat Infection occurs after rat flea bite Rickettsia multiply in gut of flea and is shed in feaces.
  • 10. Spotted fever group Rickettsiae of this group multiply in nucleus as well as in the cytoplasm of the host. Tick typhus- Transmit Transovarially in ticks, and transmission to human being is primarily by bite. Indian tick typhus- caused by R. conori Vector- Rhipicephalus sanguineus
  • 11. Rocky mountain spotted fever- Most serious form Cause – R. rickettsii Infection occurs after tick(Dermacentor andersoni) bite Incubation period – 1 week More similar to typhus fever but the rash appears earlier and is more prominent. Rickettsial pox- Mildest rickettsial Diseases of human, self limiting, Non fatal, resemble to chicken pox so Known as vesicular rickettsiosis Caused by R. akari and transmit by mite (Mus musculus)
  • 12.
  • 13. LABORATORY DIAGNOSIS Direct Microscopy Culture- Yolk sac of emryonated hens egg, male guinea pig, cell tissue culture Serological test- Weil Felix rxn, CFT, IFA, ELISA
  • 14. LABORATORY DIAGNOSIS • Isolation from experimental animals Blood is inoculated in guinea pigs/mice. Observed on 3rd – 4th week. Animal responds to different rickettsial species can vary Symptoms: Rise in temperature – all species. Scrotal inflammation, swelling, necrosis – R. typhi, R.conori, R. akari ( except R. prowazekii) This is known as Neil Mooser Rxn Specimens: Blood – collected in febrile illness Note: Rickettsia is highly infectious so specimens should be handled very carefully.
  • 15. Serology- Reliable test to confirm rickettsial diseases Antibody detection by Weil-felix test Antigen detection by IFA Weil-felix test- Heterophile agglutination test using non motile proteus strains (OX 19, OX 2, OX K) to find rickettsial antibodies in patient’s serum. Procedure: 1. Serum is diluted in three separate series of tubes followed by the addition of equal amount of OX19,OX2,OXK in 3 separate series of tubes. 2. Incubation at 370C for overnight. 3. Observe for agglutination
  • 16. INTERPRETATION OF WEIL-FELIX TEST • Strong Agglutination with OX 19 – means epidemic & endemic typhus. • Strong agglutination with OX 19 & OX 2 - means Spotted fever • Strong agglutination with OX K – Scrub typhus (Scrub typhus by Orientia tsutsugamushi (one of the rickettsial disease)
  • 17. IMMUNOFLUORESCENT ANTIBODY TECHNIQUE – UTILISES FLUORESCENT ANTIBODY TO DETECT RICKETTSIAL ANTIGEN IN INFECTED TISSUES
  • 18. Treatment Treatment should be started early in the first week of illness. Doxycycline (first choice) Tetracycline (alternate) PROPHYLAXIS Vector control